產(chǎn)品詳情
簡(jiǎn)單介紹:
Zosuquidartrihydrochloride
詳情介紹:
Characteristics |
PubChem CID: 153997 Salt form: N/A Zosuquidar is a potent P-glycoprotein (P-gp) inhibitor (Kd = 79 nM). Zosuquidar binds with high affinity to P-glycoprotein and inhibits P-glycoprotein-mediated multidrug resistance (MDR). Restores doxorubicin (Cat. No. 1527) sensitivity in P-gp-expressing multidrug (MDR) resistant cancer cell lines. Smiles: C1CN(CCN1CC(COC2=CC=CC3=C2C=CC=N3)O)C4C5=CC=CC=C5C6C(C6(F)F)C7=CC=CC=C47.Cl.Cl.Cl InChi: InChI=1S/C32H31F2N3O2.3ClH/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27,/h1-14,21,29-31,38H,15-20H2,3*1H/t21-,29-,30+,31?,/m1.../s1 Inchi Key: ZPFVQKPWGDRLHL-ZLYBXYBFSA-N |
Purity | ≥ 98?% by HPLC |
Chemical Name | (αR)-4-[(1aα,6α,10bα)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol trihydrochloride; LY335979 |
Formula | C??H??FN?O.3HCl |
Permeability | Cell-permeable |
Background | Synonyms: (αR)-4-[(1aα,6α,10bα)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol trihydrochloride, LY335979 |
Molecular Weight | 636.99 g/mol |
CAS-No | 167465-36-3 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from air and moisture |
Storage | -20 °C |
Expiry Date | 36 months |